Virtu Financial LLC - CONATUS PHARMACEUTICALS INC ownership

CONATUS PHARMACEUTICALS INC's ticker is CNAT and the CUSIP is 20600T108. A total of 40 filers reported holding CONATUS PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 0.25 and the average weighting 0.0%.

Quarter-by-quarter ownership
Virtu Financial LLC ownership history of CONATUS PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2019$4,000
-42.9%
10,060
-56.7%
0.00%
-100.0%
Q3 2019$7,000
-72.0%
23,252
-75.5%
0.00%0.0%
Q2 2019$25,000
-83.3%
94,842
+266.8%
0.00%
-88.9%
Q3 2018$150,000
+163.2%
25,860
+94.6%
0.01%
+200.0%
Q2 2018$57,000
-63.7%
13,288
-53.5%
0.00%
-62.5%
Q3 2017$157,00028,5750.01%
Other shareholders
CONATUS PHARMACEUTICALS INC shareholders Q2 2019
NameSharesValueWeighting ↓
Kalos Management, Inc. 47,500$12,0000.01%
Virtu Financial LLC 94,842$25,0000.00%
ACADIAN ASSET MANAGEMENT LLC 467,425$121,0000.00%
REILLY FINANCIAL ADVISORS, LLC 22,011$6,0000.00%
A.R.T. Advisors, LLC 60,430$16,0000.00%
GOLDMAN SACHS GROUP INC 25,350$7,0000.00%
MORGAN STANLEY 1,019$00.00%
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM 24,900$6,0000.00%
WOLVERINE TRADING, LLC 30,900$8,0000.00%
WOLVERINE TRADING, LLC 26,779$7,0000.00%
View complete list of CONATUS PHARMACEUTICALS INC shareholders